Peter Gray - 29 Jul 2021 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: Director
Issuer ticker: JAZZ
Reported as of: 29 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Aug 2021, 18:12:49 UTC
Next SEC filing: 10 Aug 2021
Source filing: View source filing
Reporting owner signature: By: /s/Adam Guttmann, as attorney in fact For: Peter Gray

Key filing fact

Peter Gray filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 02 Aug 2021.

Key facts

This page summarizes Peter Gray's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Aug 2021, 18:12.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +2,246
Change %: +19%
Price: $0.000000
Shares after: 14,266
Date: 29 Jul 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022.